Cargando…

ADAM9 Mediates Triple-Negative Breast Cancer Progression via AKT/NF-κB Pathway

Upregulation of a disintegrin and metalloprotease 9 (ADAM9) is correlated with progression of cancers, such as prostate, bladder, and pancreatic cancers. However, its role in triple-negative breast cancer (TNBC) is still unclear. Our study aimed to investigate whether ADAM9 is upregulated and promot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Rui, Cho, William C. S., Ma, Victor, Cheuk, Wah, So, Yik-Ka, Wong, S. C. Cesar, Zhang, Mingrong, Li, Cong, Sun, Yujie, Zhang, Hong, Chan, Lawrence W. C., Tian, Mei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317048/ https://www.ncbi.nlm.nih.gov/pubmed/32637415 http://dx.doi.org/10.3389/fmed.2020.00214

Ejemplares similares

Anti-cancer Activity of Centipeda minima Extract in Triple Negative Breast Cancer via Inhibition of AKT, NF-κB, and STAT3 Signaling Pathways
por: Lee, Magnolia Muk-Lan, et al.
Publicado: (2020)

Eugenol modulates the NOD1-NF-κB signaling pathway via targeting NF-κB protein in triple-negative breast cancer cells
por: Shi, Xiaoyu, et al.
Publicado: (2023)

Licochalcone A Inhibits Proliferation and Metastasis of Colon Cancer by Regulating miR-1270/ADAM9/Akt/NF-κB axis
por: Pan, Changhai, et al.
Publicado: (2023)

The role of NF-κB and Elk-1 in the regulation of mouse ADAM17 expression
por: Wawro, Karolina, et al.
Publicado: (2019)

Anthocyanidins Inhibit Growth and Chemosensitize Triple-Negative Breast Cancer via the NF-κB Signaling Pathway
por: Aqil, Farrukh, et al.
Publicado: (2021)

Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway
por: Li, Ting, et al.
Publicado: (2014)

F2r negatively regulates osteoclastogenesis through inhibiting the Akt and NFκB signaling pathways
por: Zhang, Yan, et al.
Publicado: (2020)

Indole-2-Carboxamide Derivative LG25 Inhibits Triple-Negative Breast Cancer Growth By Suppressing Akt/mTOR/NF-κB Signalling Pathway
por: Xu, Xiaohong, et al.
Publicado: (2019)

ADAM12 is A Potential Therapeutic Target Regulated by Hypomethylation in Triple-Negative Breast Cancer
por: Mendaza, Saioa, et al.
Publicado: (2020)

Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells
por: Caiazza, F, et al.
Publicado: (2015)

Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling
por: Huang, Hao, et al.
Publicado: (2021)

OGDHL Is a Modifier of AKT-Dependent Signaling and NF-κB Function
por: Sen, Tanusree, et al.
Publicado: (2012)

Curcumin Targeting NF-κB/Ubiquitin-Proteasome-System Axis Ameliorates Muscle Atrophy in Triple-Negative Breast Cancer Cachexia Mice
por: Zhang, Jin, et al.
Publicado: (2022)

Inhibited Expression of NLRP12 Promotes the Development of Triple-Negative Breast Cancer by Activating the NF-κB Pathway
por: Kuang, Wenbin, et al.
Publicado: (2023)

TCOF1 upregulation in triple-negative breast cancer promotes stemness and tumour growth and correlates with poor prognosis
por: Hu, Jianyang, et al.
Publicado: (2021)

ROR activation by Nobiletin enhances antitumor efficacy via suppression of IκB/NF-κB signaling in triple-negative breast cancer
por: Kim, Eunju, et al.
Publicado: (2022)

Disabling the Nuclear Translocalization of RelA/NF-κB by a Small Molecule Inhibits Triple-Negative Breast Cancer Growth
por: Kanzaki, Hirotaka, et al.
Publicado: (2021)

NF-κB signaling in inflammation
por: Liu, Ting, et al.
Publicado: (2017)

NF-κB in inflammation and renal diseases
por: Zhang, Haisong, et al.
Publicado: (2015)

β-Elemene Enhances the Chemotherapeutic Effect of 5-Fluorouracil in Triple-Negative Breast Cancer via PI3K/AKT, RAF-MEK-ErK, and NF-κB Signaling Pathways
por: Su, Pengyu, et al.
Publicado: (2020)

Sevoflurane Modulates AKT Isoforms in Triple Negative Breast Cancer Cells. An Experimental Study
por: Tiron, Crina E., et al.
Publicado: (2021)

Celastrol Inhibits Migration and Invasion of Triple-Negative Breast Cancer Cells by Suppressing Interleukin-6 via Downregulating Nuclear Factor-κB (NF-κB)
por: Yan, Fei, et al.
Publicado: (2020)

A BRCA1 deficient, NFκB driven immune signal predicts good outcome in triple negative breast cancer
por: Buckley, Niamh E., et al.
Publicado: (2016)

An EZH2-NF-κB regulatory axis drives expression of pro-oncogenic gene signatures in triple negative breast cancer
por: Dardis, Gabrielle J., et al.
Publicado: (2023)

KPT‐330 and Y219 exert a synergistic antitumor effect in triple‐negative breast cancer through inhibiting NF‐κB signaling
por: Wen, Tiantian, et al.
Publicado: (2023)

Ipatasertib, a novel Akt inhibitor, induces transcription factor FoxO3a and NF-κB directly regulates PUMA-dependent apoptosis
por: Sun, Li, et al.
Publicado: (2018)

Differential gene expression and AKT targeting in triple negative breast cancer
por: Lin, Feng-Mao, et al.
Publicado: (2019)

Role of AMPK and Akt in triple negative breast cancer lung colonization
por: Johnson, Jeremy, et al.
Publicado: (2021)

Acidosis promotes invasiveness of breast cancer cells through ROS-AKT-NF-κB pathway
por: Gupta, Subash C., et al.
Publicado: (2014)

Immunomodulatory activity of polysaccharides from Brassica rapa by activating Akt/NF-κB signaling
por: Guo, Weiwei, et al.
Publicado: (2021)

Feedback loop in miR‐449b‐3p/ADAM17/NF‐κB promotes metastasis in nasopharyngeal carcinoma
por: Fei, Qian, et al.
Publicado: (2019)

TBK1 controls IgA class switching by negatively regulating noncanonical NF-κB signaling
por: Jin, Jin, et al.
Publicado: (2012)

ADAM23 in Cardiomyocyte Inhibits Cardiac Hypertrophy by Targeting FAK‐AKT Signaling
por: Xiang, Mei, et al.
Publicado: (2018)

Icariin‐induced inhibition of SIRT6/NF‐κB triggers redox mediated apoptosis and enhances anti‐tumor immunity in triple‐negative breast cancer
por: Song, Linjiang, et al.
Publicado: (2020)

Lippia origanoides extract induces cell cycle arrest and apoptosis and suppresses NF-κB signaling in triple-negative breast cancer cells
por: Raman, Vishak, et al.
Publicado: (2017)

STAT3/NF-κB-Regulated Lentiviral TK/GCV Suicide Gene Therapy for Cisplatin-Resistant Triple-Negative Breast Cancer
por: Kuo, Wei-Ying, et al.
Publicado: (2017)

Anticancer Effects of ACT001 via NF-κB Suppression in Murine Triple-Negative Breast Cancer Cell Line 4T1
por: Liu, Yanyang, et al.
Publicado: (2020)

Knockdown of Pyruvate Kinase M Inhibits Cell Growth and Migration by Reducing NF-κB Activity in Triple-Negative Breast Cancer Cells
por: Ma, Chaobing, et al.
Publicado: (2019)

Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer
por: Aspros, Kirsten G. M., et al.
Publicado: (2022)

Arnicolide D Inhibits Triple Negative Breast Cancer Cell Proliferation by Suppression of Akt/mTOR and STAT3 Signaling Pathways
por: Qu, Zhao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3ja7ehblev7jurqch86emhofmt